GO:0061032 visceral serous pericardium development: Epicardium Formation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0061032 (visceral serous pericardium development) describes the progression of the inner layer of the pericardium, also called the epicardium, from its formation to its mature structure.
• The visceral serous pericardium is a mesothelial layer that covers the myocardium and is essential for heart development, providing progenitor cells and paracrine signals.
• Epicardial cells undergo epithelial-to-mesenchymal transition (EMT) to generate fibroblasts, smooth muscle cells, and pericytes that support coronary vessel formation.
• Disruption of epicardial development is linked to congenital heart defects, pericardial diseases, and impaired cardiac repair after injury.
• Key genes driving this process include WT1, TBX18, TCF21, and SNAI1, which regulate epicardial specification, EMT, and differentiation.
• Research models such as human iPSC-derived heart tissue and conditional knockout mice are used to study epicardial development and disease.
Description
The visceral serous pericardium, also known as the epicardium, is the inner layer of the pericardium that directly covers the heart muscle. Its development, described by the Gene Ontology term GO:0061032, is a critical process in embryonic heart formation, ensuring the heart is properly enclosed and supported. This process involves the specification of epicardial progenitor cells, their migration to the heart surface, and their subsequent differentiation into various cell types that contribute to the heart's structure and function. Understanding visceral serous pericardium development is essential for researchers studying congenital heart defects, cardiac regeneration, and pericardial pathologies. The epicardium serves not only as a protective layer but also as a source of signaling molecules and progenitor cells that are indispensable for coronary vessel development and myocardial growth. Consequently, elucidating the molecular mechanisms governing this process can provide insights into novel therapeutic strategies for heart disease and repair.
visceral serous pericardium development At A Glance
| GO ID | GO:0061032 |
|---|---|
| GO term | visceral serous pericardium development |
| Ontology | biological_process |
| Synonym | epicardium development |
| Major function | Formation and maturation of the inner layer of the pericardium, which covers the heart and supports coronary vessel development. |
| Related process | Epithelial-to-mesenchymal transition (EMT) of epicardial cells. |
| Key cell types | Epicardial mesothelial cells, epicardium-derived cells (EPDCs). |
| Associated diseases | Congenital heart defects, pericarditis, impaired cardiac repair. |
| Research models | Mouse knockouts, human iPSC-derived cardiac tissues, zebrafish. |
What Is GO:0061032?
GO:0061032, visceral serous pericardium development, is defined as the progression of the visceral serous pericardium from its formation to its mature structure. The visceral serous pericardium is the inner layer of the pericardium, a double-walled sac that encloses the heart. This term encompasses the developmental events that lead to a fully formed epicardium, including cell specification, migration, and differentiation.
Why Is visceral serous pericardium development Important in Cell Biology?
Visceral serous pericardium development is fundamental to heart formation and function. The epicardium provides mechanical protection, serves as a source of progenitor cells for coronary vessels and cardiac fibroblasts, and secretes paracrine factors that promote myocardial proliferation and survival. Defects in this process can lead to congenital heart anomalies, pericardial diseases, and compromised cardiac repair after injury. Therefore, understanding the molecular and cellular mechanisms of epicardial development is crucial for advancing cardiovascular research and developing regenerative therapies.
• Provides a protective mesothelial covering for the heart.
• Serves as a source of progenitor cells for coronary smooth muscle, pericytes, and fibroblasts.
• Secretes trophic factors that support myocardial growth and survival.
• Plays a key role in coronary vessel formation during development.
• Its dysfunction is associated with congenital heart defects and pericardial diseases.
• Contributes to cardiac repair processes, although adult epicardium is largely quiescent.
• Is a target for regenerative medicine strategies aiming to reactivate epicardial cells after injury.
• Relevant to Hutchinson-Gilford progeria syndrome, where epicardial integration is impaired.
• Involved in the pathology of pericarditis and pericardial effusions.
• Studied using advanced models like human iPSC-derived heart tissue for disease modeling.
What Happens During visceral serous pericardium development?
Specification of Epicardial Progenitors
In simple terms: Early in development, certain cells are instructed to become epicardial cells.
The visceral serous pericardium originates from a cluster of progenitor cells located near the venous pole of the heart tube, known as the proepicardial organ (PEO). These progenitors express transcription factors such as WT1 and TBX18, which are critical for their specification and subsequent migration to the heart surface. Signaling pathways including retinoic acid and BMP are involved in inducing the epicardial program.
Migration and Formation of the Epicardial Layer
In simple terms: The progenitor cells move to cover the heart and form a continuous sheet.
Proepicardial cells migrate to the surface of the myocardium, where they spread and form a continuous mesothelial layer, the epicardium. This process requires cell adhesion molecules and extracellular matrix remodeling. The epicardium then becomes the visceral serous pericardium, tightly adhering to the heart muscle.
Epicardial-to-Mesenchymal Transition (EMT)
In simple terms: Some epicardial cells change into a migratory cell type that can move into the heart tissue.
A subset of epicardial cells undergoes epithelial-to-mesenchymal transition (EMT), delaminating from the epicardial layer and migrating into the myocardium. This process is driven by transcription factors such as SNAI1, SNAI2, and TCF21, and is regulated by signaling pathways including TGF-beta, Wnt, and FGF. The resulting epicardium-derived cells (EPDCs) are multipotent and can differentiate into fibroblasts, smooth muscle cells, and pericytes.
Differentiation and Contribution to Cardiac Structures
In simple terms: The migrated cells become various cell types that help build the heart's blood vessels and connective tissue.
EPDCs contribute to the formation of coronary vessels by differentiating into smooth muscle cells and pericytes, and they also give rise to cardiac fibroblasts that produce extracellular matrix. Additionally, epicardial cells secrete paracrine factors such as IGF2, FGFs, and VEGF that promote myocardial proliferation and coronary angiogenesis.
Maturation and Maintenance of the Epicardium
In simple terms: The epicardial layer matures and becomes a stable covering that supports heart function.
After the initial developmental stages, the epicardium matures into a quiescent mesothelial layer in the adult heart. It maintains its barrier function and can be reactivated upon injury, although this response is limited in mammals. Proper maturation ensures the heart is protected and functionally integrated with the pericardial sac.
Key Genes Involved in GO:0061032 visceral serous pericardium development
Numerous genes orchestrate the specification, migration, EMT, and differentiation of epicardial cells during visceral serous pericardium development.
| Gene | Major Role | Research Relevance |
|---|---|---|
| WT1 | Transcription factor essential for epicardial specification and maintenance | Marker of epicardial progenitors; knockout leads to epicardial defects |
| TBX18 | Transcription factor required for proepicardial organ formation and epicardial EMT | Regulates epicardial development; mutations linked to cardiac anomalies |
| TCF21 | Transcription factor promoting epicardial EMT and fibroblast differentiation | Knockout results in impaired EMT and coronary defects |
| SNAI1 | Induces EMT by repressing E-cadherin | Key regulator of epicardial cell delamination |
| SNAI2 | EMT transcription factor, redundant with SNAI1 | Involved in epicardial cell migration |
| GATA4 | Transcription factor in epicardial and myocardial development | Mutations cause congenital heart defects |
| GATA6 | Regulates epicardial gene expression and coronary development | Conditional knockout affects epicardial derivatives |
| HAND2 | Transcription factor in epicardium and myocardium | Required for coronary vessel formation |
| FGF2 | Growth factor promoting epicardial cell proliferation and EMT | Exogenous FGF2 enhances epicardial activation |
| IGF2 | Paracrine factor secreted by epicardium to promote myocardial proliferation | Epicardial-specific knockout reduces cardiomyocyte proliferation |
| VEGFA | Angiogenic factor secreted by epicardium | Supports coronary vessel growth |
| TGFB1 | Cytokine inducing epicardial EMT | Inhibits or promotes EMT depending on context |
| WNT1 | Ligand activating canonical Wnt signaling in epicardium | Promotes EMT and differentiation |
| BMP2 | Growth factor involved in proepicardial induction | Regulates epicardial specification |
| RXRα | Retinoic acid receptor involved in epicardial development | Knockout leads to epicardial defects |
| ALDH1A2 | Enzyme for retinoic acid synthesis | Required for epicardial progenitor specification |
| CDH1 | E-cadherin, maintains epithelial integrity | Downregulated during EMT |
| CDH2 | N-cadherin, upregulated during EMT | Promotes mesenchymal phenotype |
How Is visceral serous pericardium development Regulated?
Visceral serous pericardium development is regulated by a complex network of signaling pathways and transcription factors. Key pathways include retinoic acid signaling, which specifies proepicardial progenitors; BMP and FGF signaling, which promote epicardial cell proliferation and EMT; and TGF-beta and Wnt signaling, which modulate EMT and differentiation. Transcription factors such as WT1, TBX18, and TCF21 act as master regulators of epicardial cell fate. Additionally, epigenetic modifications and microRNAs contribute to the temporal and spatial control of gene expression during epicardial development.
visceral serous pericardium development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| WT1 | Congenital heart defects, Wilms tumor | Conditional knockout mouse, iPSC-derived epicardium |
| TBX18 | Congenital heart defects, arrhythmias | Knockout mouse, zebrafish |
| TCF21 | Coronary artery disease, fibrosis | Knockout mouse, human iPSC-derived epicardial cells |
| SNAI1 | Epicardial EMT defects, cancer metastasis | Conditional knockout, EMT assays |
| LMNA | Hutchinson-Gilford progeria syndrome | iPSC-derived heart tissue with epicardial integration |
Congenital Heart Defects
Disruption of visceral serous pericardium development can lead to congenital heart defects, including coronary artery anomalies, ventricular septal defects, and impaired myocardial compaction. Mutations in epicardial genes such as WT1, TBX18, and TCF21 have been associated with cardiac malformations in animal models and human patients.
Pericardial Diseases
The visceral serous pericardium is the inner layer of the pericardium, and its dysfunction is implicated in pericarditis, pericardial effusion, and constrictive pericarditis. Inflammation of the pericardium can cause chest pain and hemodynamic compromise, and understanding its developmental origins may provide insights into these conditions.
Impaired Cardiac Repair
In the adult heart, the epicardium is largely quiescent, but it can be reactivated after injury. However, this response is insufficient for effective regeneration in mammals. Defects in epicardial EMT or paracrine signaling can impair cardiac repair and contribute to heart failure. Enhancing epicardial-mediated repair is a promising therapeutic strategy.
Hutchinson-Gilford Progeria Syndrome
Hutchinson-Gilford progeria syndrome (HGPS) is a premature aging disorder characterized by cardiovascular complications. Recent studies using engineered epicardium-integrated human iPSC-derived heart tissue have modeled HGPS and revealed defects in epicardial integration and function. This highlights the importance of epicardial development in disease pathology.
From visceral serous pericardium development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Role of a specific gene in epicardial specification | Knockout mouse or zebrafish |
| Effect of a point mutation on epicardial EMT | Point-mutation knock-in mouse or human iPSC-derived epicardial cells |
| Lineage tracing of epicardial cells | Cre-loxP knock-in mouse (e.g., WT1-Cre, TBX18-Cre) |
| Overexpression of a paracrine factor | Transgenic overexpression mouse or lentiviral transduction |
| Human disease modeling of epicardial defects | Patient-derived iPSCs differentiated into epicardium-integrated heart tissue |
| High-throughput screening of epicardial regulators | CRISPR library screening in human iPSC-derived epicardial cells |
How to Study the visceral serous pericardium development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lineage tracing (Cre-loxP) | Fate of epicardial cells and their derivatives | Mouse developmental studies |
| RNA-seq | Transcriptome of epicardial cells | Identification of gene expression changes during EMT |
| ATAC-seq | Chromatin accessibility | Mapping regulatory elements in epicardial development |
| Immunofluorescence | Protein localization and expression | Detection of epicardial markers (WT1, TBX18) |
| iPSC differentiation | Generation of epicardial-like cells | Human disease modeling and drug screening |
| CRISPR screening | Functional gene identification | High-throughput discovery of epicardial regulators |
| Electron microscopy | Ultrastructure of epicardial layer | Assessment of mesothelial integrity |
| Flow cytometry | Cell surface marker expression | Isolation of epicardial progenitors |
Lineage Tracing and Genetic Fate Mapping
Lineage tracing using Cre-loxP systems in mice allows researchers to follow the fate of epicardial cells during development and after injury. This method has been instrumental in identifying the contributions of epicardium-derived cells to coronary vessels and fibroblasts.
Transcriptomic and Epigenomic Profiling
RNA-seq and ATAC-seq of sorted epicardial cells at different developmental stages reveal dynamic gene expression and chromatin accessibility changes. These approaches identify key transcription factors and signaling pathways driving epicardial development.
In Vitro Differentiation of Human iPSCs
Human induced pluripotent stem cells (iPSCs) can be differentiated into epicardial-like cells and engineered into heart tissue with integrated epicardium. This platform enables disease modeling and drug testing, as demonstrated for Hutchinson-Gilford progeria syndrome.
Imaging and Histology
Confocal and electron microscopy, along with immunohistochemistry for epicardial markers (WT1, TBX18), allow visualization of epicardial layer formation and EMT in situ. Live imaging in zebrafish provides dynamic insights into epicardial cell migration.
How CRISPR Can Be Used to Study GO:0061032 visceral serous pericardium development
Knockout
CRISPR knockout of candidate genes in human iPSC-derived epicardial cells or mouse models can determine their necessity for epicardial specification, EMT, and differentiation. For example, knocking out WT1 or TBX18 abolishes epicardial formation.
Point Mutation
Introducing disease-associated point mutations (e.g., in GATA4 or TBX18) using CRISPR base editing or homology-directed repair allows researchers to study their impact on epicardial development and function.
Knock-in
Knock-in of reporter genes (e.g., GFP) or epitope tags into endogenous loci such as WT1 enables live tracking of epicardial cells and purification for downstream analyses.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of epicardial factors (e.g., IGF2, FGF2) can enhance epicardial-mediated cardiac repair and promote regeneration after injury.
How EDITGENE Supports visceral serous pericardium development Research
Researchers studying visceral serous pericardium development-related genes often need to determine whether a candidate gene is causally involved in epicardial specification, EMT, or differentiation. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell and animal models, enabling functional validation and mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for visceral serous pericardium development research.
Frequently Asked Questions About visceral serous pericardium development
What is visceral serous pericardium development?
Visceral serous pericardium development (GO:0061032) is the process by which the inner layer of the pericardium, also known as the epicardium, forms and matures during embryonic development.
What genes are involved in visceral serous pericardium development?
Key genes include WT1, TBX18, TCF21, SNAI1, SNAI2, GATA4, and GATA6, which regulate epicardial specification, EMT, and differentiation.
What is the function of the visceral serous pericardium?
It covers the heart, provides a protective barrier, and serves as a source of progenitor cells and paracrine factors that support coronary vessel formation and myocardial growth.
How is visceral serous pericardium development studied?
Researchers use lineage tracing, RNA-seq, iPSC differentiation, and CRISPR screens in model organisms and human cell models.
What diseases are linked to defects in visceral serous pericardium development?
Congenital heart defects, pericarditis, impaired cardiac repair, and Hutchinson-Gilford progeria syndrome have been associated with epicardial dysfunction.
What is the role of EMT in epicardial development?
Epithelial-to-mesenchymal transition (EMT) allows epicardial cells to delaminate and migrate into the myocardium, where they differentiate into fibroblasts, smooth muscle cells, and pericytes.
Can CRISPR be used to study epicardial development?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable functional studies of genes involved in visceral serous pericardium development.
What are epicardium-derived cells (EPDCs)?
EPDCs are multipotent cells generated from epicardial cells via EMT that contribute to coronary vessels and cardiac fibroblasts.
Why is the epicardium important for heart regeneration?
The epicardium secretes paracrine factors and can be reactivated after injury to promote cardiac repair, although this response is limited in mammals.
How does Hutchinson-Gilford progeria syndrome affect the epicardium?
HGPS models using iPSC-derived heart tissue show impaired epicardial integration and function, highlighting the role of the epicardium in disease.
Conclusion
Visceral serous pericardium development (GO:0061032) is a vital process in heart formation, encompassing the specification, migration, EMT, and differentiation of epicardial cells. These events are orchestrated by a network of transcription factors and signaling pathways, and their disruption leads to congenital heart defects and other cardiovascular diseases. Continued research using advanced models and CRISPR technologies will deepen our understanding of epicardial biology and unlock new therapeutic avenues for heart repair and regeneration.
References
- 1. Buijtendijk MFJ et al.. 2020. Development of the human heart.. Am J Med Genet C Semin Med Genet 184(1):7-22 PMID: 32048790
- 2. Lazarou E et al.. 2022. Acute Pericarditis: Update.. Curr Cardiol Rep 24(8):905-913 PMID: 35595949
- 3. Häkli M et al.. 2026. Engineering epicardium-integrated human iPSC-derived heart tissue for modelling Hutchinson-Gilford progeria syndrome.. Biofabrication 18(3) PMID: 42486147
- 8. Foglio E et al.. 2024. Epicardial EMT and cardiac repair: an update.. Stem Cell Res Ther 15(1):219 PMID: 39026298
